KeyVex › Disclosures › Congressional trades

KeyVex publishes these public financial disclosure filings as news, free and without registration, under the news-media provision of 5 U.S.C. § 13107(c). Source documents are linked on every entry.

James French Hill (House) disclosed 4 transactions

· Congressional trades · U.S. Senate Electronic Financial Disclosure / U.S. House Clerk

Amendment status is not available for House filings. A filing listed here may since have been amended.

2025-12-31 · sellSolventum Corporation Common Stock — $15,001 - $50,000
2025-12-31 · sellSFL Corporation Ltd — $15,001 - $50,000
2025-12-31 · sellPfizer, Inc. Common Stock — $100,001 - $250,000
2025-12-31 · sellKyndryl Holdings, Inc. Common Stock — $1,001 - $15,000

The complete record

Every field KeyVex holds for this filing, as its API serves it. Nothing is withheld here that the API sells.

ownerSelf
partyRepublican
stateAR
officeHill, James French (Representative)
ptr id20033661
chamberhouse
asset typeST
report urlhttps://disclosures-clerk.house.gov/public_disc/ptr-pdfs/2026/20033661.pdf
bioguide idH001072
data sourceHOUSE_CLERK_PTR
member lastHill
member nameJames French Hill
member firstJames French
state districtAR02
disclosure date2026-01-23
transaction date2025-12-31
transaction typesell
reporting lag days17
transaction natureOPEN_MARKET

Each transaction (4)

idtickercommentamount maxamount minasset nameamount range
house-20033661-4SOLV—5000015001Solventum Corporation Common Stock$15,001 - $50,000
house-20033661-3SFLSale of full position for tax loss purposes.5000015001SFL Corporation Ltd$15,001 - $50,000
house-20033661-2PFESale of full position for tax loss purposes.250000100001Pfizer, Inc. Common Stock$100,001 - $250,000
house-20033661-1KD—150001001Kyndryl Holdings, Inc. Common Stock$1,001 - $15,000

Original filing document